Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough

OBJECTIVES: To evaluate the predictive value of serum beta2-microglobulin (β2m) levels for virological breakthrough in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy.

Saved in:
Bibliographic Details
Main Authors: Ioannis S Elefsiniotis, Nikolaos Scarmeas, Irene Glynou, Konstantinos D Pantazis, Helen Kada, Christos Mavrogiannis
Format: Article
Language:English
Published: Wiley 2004-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2004/864292
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561420680560640
author Ioannis S Elefsiniotis
Nikolaos Scarmeas
Irene Glynou
Konstantinos D Pantazis
Helen Kada
Christos Mavrogiannis
author_facet Ioannis S Elefsiniotis
Nikolaos Scarmeas
Irene Glynou
Konstantinos D Pantazis
Helen Kada
Christos Mavrogiannis
author_sort Ioannis S Elefsiniotis
collection DOAJ
description OBJECTIVES: To evaluate the predictive value of serum beta2-microglobulin (β2m) levels for virological breakthrough in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy.
format Article
id doaj-art-440b2f9554764edb9cb98d24bcfaad75
institution Kabale University
issn 0835-7900
language English
publishDate 2004-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-440b2f9554764edb9cb98d24bcfaad752025-02-03T01:25:05ZengWileyCanadian Journal of Gastroenterology0835-79002004-01-0118530731310.1155/2004/864292Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological BreakthroughIoannis S Elefsiniotis0Nikolaos Scarmeas1Irene Glynou2Konstantinos D Pantazis3Helen Kada4Christos Mavrogiannis5Department of Hepatogastroenterology, University of Athens, ‘Helena Venizelou’ Hospital, Athens, GreeceNew York Presbyterian Hospital, Columbia University, New York, USADepartment of Microbiology, ‘Helena Venizelou’ Hospital, Athens, GreeceDepartment of Hepatogastroenterology, University of Athens, ‘Helena Venizelou’ Hospital, Athens, GreeceDepartment of Microbiology, ‘Helena Venizelou’ Hospital, Athens, GreeceDepartment of Hepatogastroenterology, University of Athens, ‘Helena Venizelou’ Hospital, Athens, GreeceOBJECTIVES: To evaluate the predictive value of serum beta2-microglobulin (β2m) levels for virological breakthrough in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy.http://dx.doi.org/10.1155/2004/864292
spellingShingle Ioannis S Elefsiniotis
Nikolaos Scarmeas
Irene Glynou
Konstantinos D Pantazis
Helen Kada
Christos Mavrogiannis
Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
Canadian Journal of Gastroenterology
title Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
title_full Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
title_fullStr Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
title_full_unstemmed Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
title_short Serum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
title_sort serum beta2 microglobulin levels in hepatitis b e antigen negative chronic hepatitits b patients under long term lamivudine monotherapy relationship with virological breakthrough
url http://dx.doi.org/10.1155/2004/864292
work_keys_str_mv AT ioannisselefsiniotis serumbeta2microglobulinlevelsinhepatitisbeantigennegativechronichepatititsbpatientsunderlongtermlamivudinemonotherapyrelationshipwithvirologicalbreakthrough
AT nikolaosscarmeas serumbeta2microglobulinlevelsinhepatitisbeantigennegativechronichepatititsbpatientsunderlongtermlamivudinemonotherapyrelationshipwithvirologicalbreakthrough
AT ireneglynou serumbeta2microglobulinlevelsinhepatitisbeantigennegativechronichepatititsbpatientsunderlongtermlamivudinemonotherapyrelationshipwithvirologicalbreakthrough
AT konstantinosdpantazis serumbeta2microglobulinlevelsinhepatitisbeantigennegativechronichepatititsbpatientsunderlongtermlamivudinemonotherapyrelationshipwithvirologicalbreakthrough
AT helenkada serumbeta2microglobulinlevelsinhepatitisbeantigennegativechronichepatititsbpatientsunderlongtermlamivudinemonotherapyrelationshipwithvirologicalbreakthrough
AT christosmavrogiannis serumbeta2microglobulinlevelsinhepatitisbeantigennegativechronichepatititsbpatientsunderlongtermlamivudinemonotherapyrelationshipwithvirologicalbreakthrough